Singular Genomics Systems Balance Sheet Health
Financial Health criteria checks 5/6
Singular Genomics Systems has a total shareholder equity of $179.0M and total debt of $8.9M, which brings its debt-to-equity ratio to 5%. Its total assets and total liabilities are $265.5M and $86.5M respectively.
Key information
5.0%
Debt to equity ratio
US$8.90m
Debt
| Interest coverage ratio | n/a |
| Cash | US$175.40m |
| Equity | US$179.01m |
| Total liabilities | US$86.46m |
| Total assets | US$265.47m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: OMIC's short term assets ($192.2M) exceed its short term liabilities ($18.3M).
Long Term Liabilities: OMIC's short term assets ($192.2M) exceed its long term liabilities ($68.2M).
Debt to Equity History and Analysis
Debt Level: OMIC has more cash than its total debt.
Reducing Debt: Insufficient data to determine if OMIC's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OMIC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: OMIC has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 33.2% each year.